See also this year's filing and all EDGAR filings for this company.
PDF Report 0001636050_2023_Sio_Gene_Therapies_Inc.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001636050, Sio Gene Therapies Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 71,736,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 900,000 |
| 3 | remainder_Assets | 2,444,000 |
| 4 | LiabilitiesCurrent | 13,002,000 |
| 5 | LiabilitiesNoncurrent | 1,730,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 18,163,000 |
| 9 | ResearchAndDevelopmentExpense | 53,399,000 |
| 10 | remainder_Expenses | 286,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -39,000 |
| 13 | remainder_ComprehensiveNetIncome | 2,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 75,080,000 |
| 1 | Liabilities | 14,732,000 |
| 2 | Expenses | 71,848,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 60,348,000 |
| 5 | NetIncome | -71,887,000 |
| 6 | ComprehensiveNetIncome | -71,886,000 |
| 7 | BaseVar | 80,850,500 |
| 8 | EconomicCapitalRatio | 0.711 |
Edgar->Model Mapping
Feature Distribution
Change over Time
